ibx glp-1 coverage Paving the way for expanded | Insights & Events The GLP-1 Access Gap: Mapping

Look for savings Eligible patients may qualify for manufacturer savings programs or third-party discount options

The lawsuits also assert that the companies did not sufficiently inform users about the risk of conditions like gastroparesis, cyclic vomiting syndrome, and bowel obstruction

Added in 2026: Indication for sleep apnea syndrome In April 2026, the use of Zepbound was newly approved for insurance coverage for patients with moderate or severe obstructive sleep apnea syndrome (OSAS) and a BMI of 27 or higher

The pain associated with kidney stones has been described by some as more excruciating than childbirth

At this point, many of us have heard about GLP-1 agonist (glucagon-like peptide-1) medications and their effectiveness in managing type 2 diabetes and aiding weight loss